Most interestingly, we show that the mechanism by which COMP increases the malignancy of cancer cells is related to its effect on intracellular Ca2+ metabolism, providing the cells with resistance to apoptosis and induces a metabolic switch. The gene discussed is COMP; the disease is cancer.